{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:01:09Z","timestamp":1787018469024,"version":"build-2736575974"},"reference-count":35,"publisher":"American Psychiatric Association Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.1176\/appi.ps.20250269","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:00:11Z","timestamp":1770267611000},"page":"300-309","source":"Crossref","is-referenced-by-count":1,"title":["Acceptability, Appropriateness, and Feasibility of Administering Long-Acting Injectable Antipsychotics in Community Pharmacies"],"prefix":"10.1176","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7999-5191","authenticated-orcid":false,"given":"Clayton D.","family":"English","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Zhang","sequence":"additional","affiliation":[{"name":"Washington State Pharmacy Association, Renton."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle."},{"name":"Department of Global Health, School of Public Health, University of Washington, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Bacci","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"e_1_3_2_2_2","unstructured":"Key Substance Use and Mental Health Indicators in the United States: Results From the 2021 National Survey on Drug Use and Health. Pub no PEP22-07-01-005. Rockville MD Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality 2022. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt39443\/2021NSDUHFFRRev010323.pdf"},{"key":"e_1_3_2_3_2","volume-title":"Kaplan & Sadock\u2019s Synopsis of Psychiatry","author":"Boland R","year":"2022","unstructured":"Boland R, Verduin ML, Ruiz P (eds): Kaplan & Sadock\u2019s Synopsis of Psychiatry, 12th ed. Philadelphia, Wolters Kluwer, 2022","edition":"12"},{"key":"e_1_3_2_4_2","unstructured":"Swinson Evans T Berkman N Brown C et al: Disparities Within Serious Mental Illness. Technical Brief no 25. Rockville MD Agency for Healthcare Research and Quality 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK368427\/pdf\/Bookshelf_NBK368427.pdf"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.20240110"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00039-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010042"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1007"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-021-00815-y"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.11.020"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.20220586"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001225"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0350-7"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.07.003"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-024-01441-w"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.09.003"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10488-010-0319-7"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2021.01.001"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-017-0635-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.00777"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1037\/pas0000648"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.37433\/aad.v5i2.351"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1037\/met0000462"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.4300\/JGME-5-4-18"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11020045"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.08.006"},{"key":"e_1_3_2_29_2","first-page":"e103","article-title":"Community pharmacists\u2019 attitudes toward the administration of long-acting injectable antipsychotic therapies","volume":"56","author":"Gupta S","year":"2016","unstructured":"Gupta S: Community pharmacists\u2019 attitudes toward the administration of long-acting injectable antipsychotic therapies [abstract]. J Am Pharm Assoc 2016; 56:e103","journal-title":"J Am Pharm Assoc"},{"key":"e_1_3_2_30_2","unstructured":"Pharmacy\u2019s Appointment Based Model: A Prescription Synchronization Program That Improves Adherence. Washington DC American Pharmacists Association Foundation 2013. https:\/\/naspa.us\/wp-content\/uploads\/2015\/07\/ABMWhitePaper-FINAL-201309233.pdf"},{"key":"e_1_3_2_31_2","first-page":"662","article-title":"Impact of appointment-based medication synchronization on existing users of chronic medications","volume":"21","author":"Holdford D","year":"2015","unstructured":"Holdford D, Saxena K: Impact of appointment-based medication synchronization on existing users of chronic medications. J Manag Care Spec Pharm 2015; 21:662\u2013669","journal-title":"J Manag Care Spec Pharm"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2018.02.010"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-018-0619-7"},{"key":"e_1_3_2_34_2","unstructured":"Pharmacist Authority to Administer Long-Acting Injectable Antipsychotic Medications. North Chesterfield VA National Alliance of State Pharmacy Associations 2024. https:\/\/naspa.us\/wp-content\/uploads\/2024\/05\/2024-LAIA-Med-Admin-Map.pdf"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2024.04.107"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2024.102256"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:40:00Z","timestamp":1775058000000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ps.20250269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"alternative-id":["10.1176\/appi.ps.20250269"],"URL":"https:\/\/doi.org\/10.1176\/appi.ps.20250269","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}